» Authors » Anna J Podolanczuk

Anna J Podolanczuk

Explore the profile of Anna J Podolanczuk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 650
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Flack K, George M, Kim J, Hsu J, Podolanczuk A, Hoffman E, et al.
Respir Med . 2025 Jan; 238:107955. PMID: 39855480
Antinuclear antibodies (ANA) are often found in ILD; whether ANA is associated with radiographic progression of quantitive interstitial lung changes is unknown. We performed longitudinal analyses of adults in the...
2.
Savvaides T, Di Vitantonio T, Edgar A, OBeirne R, Krishnan J, Kaner R, et al.
J Scleroderma Relat Disord . 2025 Jan; :23971983241303655. PMID: 39777214
Background: Systemic sclerosis is a chronic and rare connective tissue disease with multiorgan effects, including interstitial lung disease (ILD). Navigating systemic sclerosis-interstitial lung disease presents a challenge for patients due...
3.
Aronson K, Holbrook N, Edgar A, Anderson M, Krishnan J, Kaner R, et al.
CHEST Pulm . 2025 Jan; 2(4). PMID: 39742153
Background: Behavioral and educational interventions are promising approaches to improve health-related quality of life (HRQOL), however few have been studied in Hypersensitivity Pneumonitis (HP) or other interstitial lung diseases (ILD)....
4.
Podolanczuk A, Fernandez Perez E
Am J Manag Care . 2024 Nov; 30(7 Suppl):S122-S130. PMID: 39495032
The term "progressive pulmonary fibrosis" or "PPF" is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF)....
5.
Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, et al.
Ann Am Thorac Soc . 2024 Oct; PMID: 39405163
Rationale: Rheumatoid arthritis (RA) has been implicated in interstitial lung disease (ILD) as majority of studies have been comprised of patients with known RA. However, it remains unclear whether an...
6.
Podolanczuk A, Tomassetti S
Am J Respir Crit Care Med . 2024 Sep; 210(12):1394-1395. PMID: 39312209
No abstract available.
7.
Podolanczuk A, Raghu G
Eur Respir J . 2024 Aug; 64(2). PMID: 39174288
No abstract available.
8.
Podolanczuk A, Maher T, Drake W, Sime P, Eickelberg O, DeMeo D, et al.
Am J Respir Crit Care Med . 2024 Aug; 210(4):373-374. PMID: 39145623
No abstract available.
9.
Rofail D, Somersan-Karakaya S, Mylonakis E, Choi J, Przydzial K, Marquis S, et al.
J Patient Rep Outcomes . 2024 Aug; 8(1):87. PMID: 39117891
Background: The field of long COVID research is rapidly evolving, however, tools to assess and monitor symptoms and recovery of the disease are limited. The objective of the present study...
10.
Berger K, Podolanczuk A
Am J Respir Crit Care Med . 2024 Jul; 210(4):383-385. PMID: 38980193
No abstract available.